Trends in off-label β-blocker use: A secondary data analysis
- 31 October 2006
- journal article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 28 (10), 1736-1746
- https://doi.org/10.1016/j.clinthera.2006.10.015
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Off-label Prescribing Among Office-Based PhysiciansArchives of Internal Medicine, 2006
- Off‐Label Prescribing of Drugs in Specialty Headache PracticeHeadache: The Journal of Head and Face Pain, 2004
- The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric PatientsDrug Safety, 2004
- Adverse drug reactions and off‐label prescribing for paediatric outpatients: a one‐year survey of spontaneous reports in SwedenPharmacoepidemiology and Drug Safety, 2003
- Off-label prescribing in the treatment of dermatologic diseaseJournal of the American Academy of Dermatology, 2002
- Uses of Drugs Not Described in the Package Insert (Off-Label Uses)Published by American Academy of Pediatrics (AAP) ,2002
- The role of marketing in pharmaceutical research and development.PharmacoEconomics, 2002
- Unlicensed and Off-Label Drug Use in ChildrenDrug Safety, 2002
- HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approachesJournal of Cardiac Failure, 1999
- 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1999